Analysts’ Updated EPS Estimates for November 19th (ATNM, BNS, BRBR, DTC, DY, ENPH, ETG, KBR, NTLA, OCSL)
Analysts’ updated eps estimates for Tuesday, November 19th: Actinium Pharmaceuticals (NYSE:ATNM) had its overweight rating reiterated by analysts at Stephens. The firm currently has a $5.00 price target on the stock. Bank of Nova Scotia (TSE:BNS) (NYSE:BNS) was upgraded by analysts at Canaccord Genuity Group Inc. from a hold rating to a buy rating. Canaccord […]
More Stories
Iranian President Says His Country in ‘Full-Fledged War’ With US, Europe, and Israel
By Jack Phillips Iranian President Masoud Pezeshkian said Saturday that the Iranian regime is in a full-scale war with the...
US Airline Industry Caps a Strong 2025—What Lies Ahead in 2026
By Panos Mourdoukoutas Despite a shaky start earlier in the year, U.S. airline travel reached another milestone during the 2025...
What Trump’s National Security Strategy Means for Canada
By Noe Chartier Canada receives but a passing mention in the recently released U.S. National Security Strategy, but that doesn’t...
Italy Arrests 9 for Allegedly Using Charities to Fund Hamas Terrorists
By Tom Ozimek Italian authorities have arrested nine people on suspicion of financing Hamas through a network of charities operating...
Winter Weather Cancels Over 1,000 Flights Across US
By Jacki Thrapp Travelers may need to pack their patience on Dec. 27 as winter weather in the Northeast prompted...
Trump Says 2026 Midterms Will Be Referendum on Prices, Economic Success
By Tom Ozimek President Donald Trump said he expects the 2026 midterm elections to hinge on prices and perceptions of...